Ussher, M. http://orcid.org/0000-0002-0995-7955
Best, C.
Lewis, S.
McKell, J.
Coleman, T.
Cooper, S.
Orton, S.
Bauld, L.
Article History
Received: 28 April 2021
Accepted: 22 July 2021
First Online: 2 August 2021
Declarations
:
: The trial has ethical approval from North West - Liverpool Central Research Ethics Committee, obtained on 11th January 2019 (18/NW/0838). Local NHS site recruitment approvals have all been obtained. Written or verbal informed consent to participate will be obtained from all participants.
: Not applicable
: On two occasions since 2008, TC has been paid to attend and present at symposia arranged by Pierre Fabre Laboratories (PFL); PFL is a manufacturer of nicotine replacement therapy. All other authors declare that they have no competing interests.